SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2002
Commission file number 000-49602
SYNAPTICS INCORPORATED
| Delaware | 77-0118518 | |
| (State or other jurisdiction | (I.R.S. Employer | |
| of incorporation or organization) | Identification No.) |
2381 Bering Drive
San Jose, California 95131
(Address of principal executive offices)
(Zip code)
(408) 434-0110
(Registrants telephone number, including area code)
Check whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Number of shares of Common Stock outstanding at November 4, 2002: 23,363,381
SYNAPTICS INCORPORATED
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED SEPTEMBER 30, 2002
TABLE OF CONTENTS
| Page | |||||||
Part I. Financial Information |
|||||||
Item 1. Financial Statements: |
|||||||
Condensed Consolidated Balance Sheets- September 30, 2002 and June 30, 2002 (Unaudited) |
3 | ||||||
Condensed Consolidated Statements of Operations- Three Months Ended September 30, 2002 and 2001 (Unaudited) |
4 | ||||||
Condensed Consolidated Statements of Cash Flows- Three Months Ended September 30, 2002 and 2001 (Unaudited) |
5 | ||||||
Notes to Condensed Consolidated Financial Statements (Unaudited) |
6 | ||||||
Item 2. Managements Discussion and Analysis of Financial
Condition and Results of Operations |
10 | ||||||
Item 3. Quantitative and Qualitative Disclosures About Market Risk |
15 | ||||||
Item 4. Controls and Procedures |
15 | ||||||
Part II. Other Information |
|||||||
Item 5. Other Information |
15 | ||||||
Item 6. Exhibits and Reports on Form 8-K |
15 | ||||||
Signatures |
16 | ||||||
Certifications |
17 | ||||||
PART 1 FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
SYNAPTICS INCORPORATED
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
| September 30, | June 30, | |||||||||||
| 2002 | 2002 (1) | |||||||||||
| (unaudited) | ||||||||||||
ASSETS |
||||||||||||
Current assets: |
||||||||||||
Cash and cash equivalents |
$ | 35,163 | $ | 45,491 | ||||||||
Short-term investments |
29,197 | 19,689 | ||||||||||
Accounts
receivable, net of allowances of $210 and $200 at September 30, 2002 and June 30, 2002, respectively |
15,610 | 13,242 | ||||||||||
Inventories |
6,398 | 5,867 | ||||||||||
Prepaid expenses and other current assets |
3,495 | 2,964 | ||||||||||
Total current assets |
89,863 | 87,253 | ||||||||||
Property and equipment, net |
2,005 | 2,043 | ||||||||||
Goodwill |
765 | 765 | ||||||||||
Other assets |
310 | 320 | ||||||||||
Total assets |
$ | 92,943 | $ | 90,381 | ||||||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||||||
Current liabilities: |
||||||||||||
Accounts payable |
$ | 6,096 | $ | 5,867 | ||||||||
Accrued compensation |
2,232 | 2,161 | ||||||||||
Accrued warranty |
1,002 | 1,002 | ||||||||||
Income taxes payable |
2,700 | 2,646 | ||||||||||
Other accrued liabilities |
2,129 | 1,814 | ||||||||||
Capital leases and equipment financing obligations |
351 | 445 | ||||||||||
Total current liabilities |
14,510 | 13,935 | ||||||||||
Capital leases and equipment financing obligations, net of
current portion |
164 | 259 | ||||||||||
Note payable to a related party |
1,500 | 1,500 | ||||||||||
Other liabilities |
702 | 684 | ||||||||||
Commitments and contingencies |
||||||||||||
Stockholders equity: |
||||||||||||
Common stock |
23 | 23 | ||||||||||
Additional paid-in capital |
75,657 | 75,013 | ||||||||||
Deferred stock compensation |
(975 | ) | (1,085 | ) | ||||||||
Notes receivable from stockholders |
(768 | ) | (876 | ) | ||||||||
Retained earnings |
2,065 | 865 | ||||||||||
Accumulated other comprehensive income |
65 | 63 | ||||||||||
Total stockholders equity |
76,067 | 74,003 | ||||||||||
Total liabilities and stockholders equity |
$ | 92,943 | $ | 90,381 | ||||||||
| (1) | Derived from our audited financial statements as of June 30, 2002, included in our Form 10-K filed with the Securities and Exchange Commission. |
See notes to condensed consolidated financial statements.
3
SYNAPTICS INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
| Three Months Ended | |||||||||
| September 30, | |||||||||
| 2002 | 2001 | ||||||||
Net revenue |
$ | 22,177 | $ | 23,569 | |||||
Cost of revenue (1) |
12,443 | 14,607 | |||||||
Gross margin |
9,734 | 8,962 | |||||||
Operating expenses: |
|||||||||
Research and development (1) |
5,323 | 3,691 | |||||||
Selling, general, and administrative (1) |
2,604 | 2,674 | |||||||
Amortization of other acquired intangible assets |
30 | 13 | |||||||
Amortization of deferred stock compensation |
110 | 121 | |||||||
Total operating expenses |
8,067 | 6,499 | |||||||
Operating income |
1,667 | 2,463 | |||||||
Interest income |
277 | 33 | |||||||
Interest expense |
(39 | ) | (64 | ) | |||||
Income before income taxes |
1,905 | 2,432 | |||||||
Provision for income taxes |
705 | 845 | |||||||
Net income |
$ | 1,200 | $ | 1,587 | |||||
Net income per share: |
|||||||||
Basic |
$ | 0.05 | $ | 0.24 | |||||
Diluted |
$ | 0.05 | $ | 0.08 | |||||
Shares used in computing net income
per share: |
|||||||||
Basic |
23,260 | 6,623 | |||||||
Diluted |
24,840 | 20,362 | |||||||
| (1) | Cost of revenue excludes $7,000 and $7,000 of amortization of deferred stock compensation for the three months ended September 30, 2002 and 2001, respectively. Research and development expense excludes $39,000 and $49,000 of amortization of deferred stock compensation for the three months ended September 30, 2002 and 2001, respectively. Selling, general, and administrative expenses exclude $64,000 and $65,000 of amortization of deferred stock compensation for the three months ended September 30, 2002 and 2001, respectively. These amounts have been aggregated and reflected as Amortization of deferred stock compensation. |
See notes to condensed consolidated financial statements.
4
SYNAPTICS INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(in thousands)
(unaudited)
| Three Months Ended | ||||||||||
| September 30, | ||||||||||
| 2002 | 2001 | |||||||||
Operating activities |
||||||||||
Net income |
$ | 1,200 | $ | 1,587 | ||||||
Adjustments to reconcile net income to net cash provided by (used
in) operating activities: |
||||||||||
Depreciation and amortization of property and equipment |
338 | 291 | ||||||||
Amortization of other acquired intangible assets |
30 | 13 | ||||||||
Amortization of deferred stock compensation |
110 | 121 | ||||||||
Changes in operating assets and liabilities: |
||||||||||
Accounts receivable |
(2,368 | ) | (176 | ) | ||||||
Inventories |
(531 | ) | 1,869 | |||||||
Prepaid expenses and other current assets |
(531 | ) | 27 | |||||||
Other assets |
(20 | ) | (385 | ) | ||||||
Accounts payable |
229 | (1,646 | ) | |||||||
Accrued compensation |
71 | (97 | ) | |||||||
Other accrued liabilities and income taxes payable |
369 | 397 | ||||||||
Other liabilities |
18 | 21 | ||||||||
Net cash provided by (used in) operating activities |
(1,085 | ) | 2,022 | |||||||
Investing activities |
||||||||||
Purchases of short-term investments |
(11,736 | ) | | |||||||
Proceeds from sales and maturities of short-term investments |
2,230 | | ||||||||
Purchase of property and equipment |
(300 | ) | (277 | ) | ||||||
Net cash used in investing activities |
(9,806 | ) | (277 | ) | ||||||
Financing activities |
||||||||||
Payments on capital leases and equipment financing obligations |
(189 | ) | (146 | ) | ||||||
Common stock issued under ESPP and stock option plans |
644 | 110 | ||||||||
Repayment of notes receivable from stockholders |
108 | | ||||||||
Net cash provided by (used in) financing activities |
563 | (36 | ) | |||||||
Increase (decrease) in cash and cash equivalents |
(10,328 | ) | 1,709 | |||||||
Cash and cash equivalents at beginning of period |
45,491 | 3,766 | ||||||||
Cash and cash equivalents at end of period |
35,163 | $ | 5,475 | |||||||
Supplemental disclosures of cash flow information |
||||||||||
Cash paid for interest |
10 | 35 | ||||||||
Cash paid for taxes |
651 | 375 | ||||||||
See notes to condensed consolidated financial statements.
5
SYNAPTICS INCORPORATED
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
| 1. | Basis of Presentation |
The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission and generally accepted accounting principles. However, certain information or footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations. In our opinion, the statements include all adjustments (which are of a normal and recurring nature) necessary for the fair presentation of the results of the interim periods presented. The results of operations for the interim periods are not necessarily indicative of the operating results for the full fiscal year or any future period. These financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our annual report on Form 10-K for the year ended June 30, 2002.
The consolidated financial statements include our financial statements and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.
Our fiscal year ends on the last Saturday in June. For ease of presentation, the accompanying financial statements have been shown as ending on June 30 and calendar quarter ends for all annual, interim, and quarterly financial statement captions.
| 2. | Net Income Per Share |
Basic net income per share amounts have been computed using the weighted-average number of shares of common stock outstanding during each period, less shares subject to repurchase. Diluted net income per share amounts also include the effect of potentially dilutive securities, including stock options, warrants, and convertible preferred stock, when dilutive.
The following table presents the computation of basic and diluted net income per share (in thousands, except per share amounts):
| Three Months Ended | ||||||||||
| September 30, | ||||||||||
| 2002 | 2001 | |||||||||
Numerator for basic and diluted net income per share: |
||||||||||
Net income |
$ | 1,200 | $ | 1,587 | ||||||
Denominator for basic net income per share: |
||||||||||
Weighted average common shares outstanding |
23,260 | 6,647 | ||||||||
Less: Weighted average shares subject to
repurchase |
| (24 | ) | |||||||
Denominator for basic net income per share |
23,260 | 6,623 | ||||||||
Denominator for diluted net income per share: |
||||||||||
Shares used above, basic |
23,260 | 6,623 | ||||||||
Dilutive stock options |
1,580 | 2,605 | ||||||||
Dilutive warrants |
| 23 | ||||||||
Dilutive preferred stock |
| 11,074 | ||||||||
Dilutive contingent shares |
| 37 | ||||||||
Denominator for diluted net income per share |
24,840 | 20,362 | ||||||||
Net income per share: |
||||||||||
Basic |
$ | 0.05 | $ | 0.24 | ||||||
Diluted |
$ | 0.05 | $ | 0.08 | ||||||
6
| 3. | Cash Equivalents and Short-term Investments |
Highly liquid debt securities with insignificant interest rate risk and original maturities of three months or less are classified as cash equivalents. Debt securities with maturities greater than three months are considered available-for-sale and are classified as short-term investments. Our policy is to ensure the safety and preservation of our invested funds by investing in high credit-quality financial instruments.
All of our short-term investments were classified as available-for-sale as of the balance sheet dates presented and, accordingly, are reported at fair value with unrealized gains and losses recorded as a component of accumulated other comprehensive income in stockholders equity.
As of September 30, 2002, cash, cash equivalents, and short-term investments consisted of the following (in thousands):
| Gross | Gross | ||||||||||||||||
| Amortized | Unrealized | Unrealized | Fair | ||||||||||||||
| Cost | Gains | Losses | Value | ||||||||||||||
Cash and cash equivalents: |
|||||||||||||||||
Cash |
$ | 3,255 | $ | | $ | | $ | 3,255 | |||||||||
Certificate of
deposit |
24 | | | 24 | |||||||||||||
Money
market |
16,907 | | | 16,907 | |||||||||||||
Municipal
securities |
14,977 | | | 14,977 | |||||||||||||
| $ | 35,163 | $ | | $ | | $ | 35,163 | ||||||||||
Short-term investments: |
|||||||||||||||||
Municipal securities |
$ | 29,132 | $ | 65 | $ | | $ | 29,197 | |||||||||
| 4. | Comprehensive Income |
Comprehensive income includes all changes in stockholders equity during a period except those resulting from investments by owners and distributions to owners. Other comprehensive income comprises unrealized gains and losses on available-for-sale securities. Total comprehensive income for the three months ended September 30, 2002 and 2001 was $1,202,000 and $1,587,000, respectively. Accumulated other comprehensive income amounted to $65,000 and $0 as of September 30, 3002 and 2001, respectively. For the three months ended September 30, 2002 and 2001 the change in unrealized gain on marketable equity securities was $2,000 and $0, respectively.
| 5. | Goodwill and Other Acquired Intangible Assets |
Goodwill represents the excess purchase price of net tangible and intangible assets acquired in business combinations over their estimated fair value. Other acquired intangible assets primarily represent core technology and patent rights. In June 2001, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 141, Business Combinations, and No. 142, Goodwill and Other Intangible Assets (SFAS 141 and SFAS 142, respectively). Adoption of SFAS 141 on July 1, 2001, did not have any impact on our financial position or historical results of operations. However, certain intangible assets that did not meet the new criteria for recognition as a separate class of intangible assets have been reclassified as part of goodwill for all periods presented.
SFAS 142 supersedes APB Opinion No. 17, Intangible Assets, and requires goodwill and other intangible assets that have an indefinite useful life to no longer be amortized; however, these assets must be reviewed at least annually for impairment. We had previously amortized goodwill over its estimated useful life of three years; however, pursuant to the adoption of SFAS 142 on July 1, 2001, the goodwill is no longer amortized. We continue to amortize separately identifiable intangible assets with finite useful lives over periods ranging from two to three years and the adoption of SFAS 142 had no impact on such identifiable intangible assets. In our opinion, no material impairment existed at September 30, 2002.
7
Other acquired intangible assets consisted of the following (in thousands):
| September 30, | June 30, | ||||||||